Is BCRX a good stock to buy? We came across a bullish thesis on BioCryst Pharmaceuticals, Inc. on BioEquity Watch’s Substack. In this article, we will summarize the bulls’ thesis on BCRX. BioCryst Pharmaceuticals, Inc.'s share was trading at $8.33 as of June 9th. BCRX’s trailing and forward P/E were 7.46 and 72.99 respectively according to Yahoo Finance.
[caption id="attachment_522188" align="aligncenter" width="750"]BioCryst Pharmaceuticals, Inc., a biotechnology company, developing and commercializing medicines for...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.